Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Angewandte Chemie (International Ed. in English)
|
September 4, 2008
Simple Access to the Non-Oxidizing Lewis superacid PhF --> Al(OR(F))3 (R(F) = C(CF3)3)
Lutz O Müller, Daniel Himmel, Julia Stauffer, et al.
Plos One
|
January 14, 2014
Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort
Shannon Rose, Richard E Frye, John Slattery, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
October 1, 2009
Synthesis, coordination chemistry and bonding of strong N-donor ligands incorporating the 1H-pyridin-(2E)-ylidene (PYE) motif
Qi Shi, Robert J Thatcher, John Slattery, et al.
Scientific Reports
|
January 30, 2016
Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome
Richard E Frye, Devin Cox, John Slattery, et al.
Blood
|
February 22, 2003
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen
Jerald P Radich, Ted Gooley, William Bensinger, et al.
Frontiers in Psychiatry
|
October 2, 2019
Inheritance of HLA-Cw7 Associated With Autism Spectrum Disorder (ASD)
Terry Harville, Bobbie Rhodes-Clark, Sirish C Bennuri, et al.
Journal of Neurotrauma
|
June 10, 2010
Resting cerebral blood flow alterations in chronic traumatic brain injury: an arterial spin labeling perfusion FMRI study
Junghoon Kim, John Whyte, Sunil Patel, et al.
Frontiers in Neuroscience
|
March 26, 2016
Blocking and Binding Folate Receptor Alpha Autoantibodies Identify Novel Autism Spectrum Disorder Subgroups
Richard E Frye, Leanna Delhey, John Slattery, et al.
Metabolic Brain Disease
|
August 31, 2017
Bioenergetic variation is related to autism symptomatology
Leanna Delhey, Ekim Nur Kilinc, Li Yin, et al.
Blood
|
April 4, 2002
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease
Paul A Carpenter, Frederick R Appelbaum, Lawrence Corey, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Angewandte Chemie (International Ed. in English)
|
September 4, 2008
Simple Access to the Non-Oxidizing Lewis superacid PhF --> Al(OR(F))3 (R(F) = C(CF3)3)
Lutz O Müller, Daniel Himmel, Julia Stauffer, et al.
Plos One
|
January 14, 2014
Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort
Shannon Rose, Richard E Frye, John Slattery, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
October 1, 2009
Synthesis, coordination chemistry and bonding of strong N-donor ligands incorporating the 1H-pyridin-(2E)-ylidene (PYE) motif
Qi Shi, Robert J Thatcher, John Slattery, et al.
Scientific Reports
|
January 30, 2016
Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome
Richard E Frye, Devin Cox, John Slattery, et al.
Blood
|
February 22, 2003
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen
Jerald P Radich, Ted Gooley, William Bensinger, et al.
Frontiers in Psychiatry
|
October 2, 2019
Inheritance of HLA-Cw7 Associated With Autism Spectrum Disorder (ASD)
Terry Harville, Bobbie Rhodes-Clark, Sirish C Bennuri, et al.
Journal of Neurotrauma
|
June 10, 2010
Resting cerebral blood flow alterations in chronic traumatic brain injury: an arterial spin labeling perfusion FMRI study
Junghoon Kim, John Whyte, Sunil Patel, et al.
Frontiers in Neuroscience
|
March 26, 2016
Blocking and Binding Folate Receptor Alpha Autoantibodies Identify Novel Autism Spectrum Disorder Subgroups
Richard E Frye, Leanna Delhey, John Slattery, et al.
Metabolic Brain Disease
|
August 31, 2017
Bioenergetic variation is related to autism symptomatology
Leanna Delhey, Ekim Nur Kilinc, Li Yin, et al.
Blood
|
April 4, 2002
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease
Paul A Carpenter, Frederick R Appelbaum, Lawrence Corey, et al.
Page
of 3